Neurociencia del consumo y dependencia de sustancias psicoactivas

More documents

Recommendations

Info

5. BASES GENÉTICAS DE LAS FARMACODEPENDENCIASVandenbergh DJ y colab. (2000) Long forms of the dopamine receptor (DRD4)gene VNTR are more prevalent in substance abusers: no interaction with functionalalleles of the catechol-o-methyltransferase (COMT) gene. AmericanJournal of Medical Genetics, 96:678–683.van den Bree MB, Svikis DS, Pickens RW (1998) Genetic influences in antisocialpersonality and drug use disorders. Drug and Alcohol Dependence,49:177–187.van den Bree MB y colab. (1998) Genetic analysis of diagnostic systems of alcoholismin males. Biological Psychiatry, 43:139–145.Vanyukov MM, Tarter RE (2000) Genetic studies of substance abuse. Drug andAlcohol Dependence, 59:101–123.Vanyukov MM y colab. (1995) Preliminary evidence for an association of a dinucleotiderepeat polymorphism at the MAOA gene with early onsy colabcoholism/substanceabuse. American Journal of Medical Genetics, 60:122–126.Vanyukov MM y colab. (2000) Antisociality, substance dependence, and theDRD5 gene: a preliminary study. American Journal of Medical Genetics,96:654–658.Veenstra-van der Weele J, Anderson GM, Cook EH Jr (2000) Pharmacogeneticsand the serotonin system: initial studies and future directions. European Journalof Pharmacology, 410:165–181.Viken RJ y colab. (1999) Longitudinal analyses of the determinants of drinking andof drinking to intoxication in adolescent twins. Behavior Genetics, 29:455–461.Vogt I (2000a) Risikoperioden im lebenszyklus. [Periodos de riesgo en el ciclo devida.] En: Uchtenhagen A, Zieglgänsberger W, eds. Suchtmedizin: konzepte, strategienund therapeutsches management. [Medicina de las adicciones: conceptos, estrategiasy manejo terapéutico.] Munich, Urban y Fischer Verlag: 212–215.Vogt I (2000b) Geschlechtsspezifische gefährdungen. [Peligros específicos alsexo.] En: Uchtenhagen A, Zieglgänsberger W, eds. Suchtmedizin: konzepte, strategienund therapeutsches management. [Medicina de las adicciones: conceptos, estrategiasy manejo terapéutico.] Munich, Urban y Fischer Verlag: 215–219.Wall TL y colab. (2000) Hangover symptoms in Asian Americans with variationsin the aldehyde dehydrogenase (ALDH2) gene. Journal of Studies on Alcohol,61:13–17.Wand GS y colab. (2002) The mu-opioid receptor gene polymorphism (A118G)alters HPA axis activation induced by opioid receptor blockade.Neuropsychopharmacology, 26:106–114.Wahlsten D (1999) Single-gene influences on brain and behavior. AnnualReview of Psychology, 50:599–624.Watanabe J, Hayashi S, Kawajiri K (1994) Different regulation and expressionof the human CYP2E1 gene due to the RsaI polymorphism in the 5'-flankingregion. Journal of Biochemistry (Tokio), 116:321–326.Weathermon R, Crabb D (1999) Alcohol and medication interactions. AlcoholHealth and Research World, 23:40–54.Whitfield JB y colab. (1998) ADH genotypes and alcohol use and dependencein Europeans. Alcoholism: Clinical and Experimental Research, 22:1463–1469.167
NEUROCIENCIA DEL CONSUMO Y DEPENDENCIA DE SUSTANCIAS PSICOACTIVASYang M y colab. (2001) Individual differences in urinary cotinine levels inJapanese smokers: relation to genetic polymorphism of drug-metabolizingenzymes. Cancer Epidemiology and Biomarkers Preview, 10:589–593.Yoshihara E y colab. (2000a) The effects of the ALDH2*1/2, CYP2E1 C1/C2and C/D genotypes on blood ethanol elimination. Drug and Chemical Toxicology,23:371–379.Yoshihara E y colab. (2000b) The human serotonin receptor gene (HTR2) MspIpolymorphism in Japanese schizophrenic and alcoholic patients.Neuropsychobiology, 41:124–126.Zhang X y colab. (2001) Lack of association between smoking and CYP2A6gene polymorphisms in a Japanese population. Nihon Arukoru Yakubutsu IgakkaiZasshi, 36:486–490.Zimprich A y colab. (2000) An allelic variation in the human prodynorphin genepromoter alters stimulus-induced expression. Journal of Neurochemistry,74:472–477.168
Page 1:
Neurociencia del consumoy dependenc
Page 4 and 5:
ÍndiceÍndicePrólogoAgradecimient
Page 6 and 7:
ÍNDICESedantes e hipnóticos 73Int
Page 8 and 9:
ÍNDICEFenotipo 148Comorbilidad 148
Page 10 and 11:
PrólogoEl uso y dependencia de sus
Page 12:
AgradecimientosLa Organización Mun
Page 22 and 23:
Capítulo 1IntroducciónEl presente
Page 25 and 26:
NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 42 and 43:
2. MECANISMOS CEREBRALES: NEUROBIOL
Page 44 and 45:
Page 46 and 47:
Page 48 and 49:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 88 and 89:
Capítulo 4Psicofarmacología de la
Page 90 and 91:
4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 92 and 93:
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
Page 106 and 107:
Page 108 and 109:
Page 110 and 111:
Page 112 and 113:
Page 114 and 115:
Page 116 and 117:
Page 118 and 119:
Page 120 and 121:
Page 122 and 123:
Page 124 and 125:
Page 126 and 127:
Page 128 and 129:
Page 130 and 131:
Page 132 and 133:
Page 134 and 135:
Page 136 and 137:
Page 138 and 139: 4. PSICOFARMACOLOGÍA DE LA DEPENDE
Page 146 and 147: Capítulo 5Bases Genéticas de lasF
Page 148 and 149: 5. BASES GENÉTICAS DE LAS FARMACOD
Page 190 and 191: Capítulo 6Trastornos ConcurrentesI
Page 192 and 193: 6. TRASTORNOS CONCURRENTES3. El uso
Page 194 and 195: 6. TRASTORNOS CONCURRENTESy Meador-
Page 196 and 197: 6. TRASTORNOS CONCURRENTESprobablem
Page 198 and 199: 6. TRASTORNOS CONCURRENTESde drogas
Page 200 and 201: 6. TRASTORNOS CONCURRENTESy Turski,
Page 202 and 203: 6. TRASTORNOS CONCURRENTESEl víncu
Page 204 and 205: 6. TRASTORNOS CONCURRENTESAlcohol y
Page 206 and 207: 6. TRASTORNOS CONCURRENTESSerotonin
Page 208 and 209: 6. TRASTORNOS CONCURRENTESFunción
Page 210 and 211: 6. TRASTORNOS CONCURRENTESRECUADRO
Page 212 and 213: 6. TRASTORNOS CONCURRENTEStos psiqu
Page 214 and 215: 6. TRASTORNOS CONCURRENTESCarol G y
Page 216 and 217: 6. TRASTORNOS CONCURRENTESdepressio
Page 218 and 219: 6. TRASTORNOS CONCURRENTESHall RG y
Page 220 and 221: 6. TRASTORNOS CONCURRENTESKapur S,
Page 222 and 223: 6. TRASTORNOS CONCURRENTESMansvelde
Page 224 and 225: 6. TRASTORNOS CONCURRENTESPetty F (
Page 226 and 227: 6. TRASTORNOS CONCURRENTESSevy S y
Page 228: 6. TRASTORNOS CONCURRENTESlesions o
Page 231 and 232: NEUROCIENCIA DEL CONSUMO Y DEPENDEN
Page 239 and 240:
Page 241 and 242:
Page 243 and 244:
Page 245 and 246:
Page 247 and 248:
Page 249 and 250:
Page 251 and 252:
Page 253 and 254:
Page 255 and 256:
Page 257 and 258:
Page 259 and 260:
Page 261 and 262:
Page 263 and 264:
Page 265 and 266:
Page 267 and 268:
Page 269 and 270:
Page 272 and 273:
Índice AnalíticoNota: los número
Page 274 and 275:
ÍNDICE ANALÍTICOAtropina 103ATV,
Page 276 and 277:
ÍNDICE ANALÍTICOpolíticas de sal
Page 278 and 279:
ÍNDICE ANALÍTICOuso de tabaco 171
Page 280 and 281:
ÍNDICE ANALÍTICOInmunoterapias pa
Page 282 and 283:
ÍNDICE ANALÍTICOParkinson, efecto
Page 284 and 285:
ÍNDICE ANALÍTICOSolventes voláti
Page 286:
Neurociencia del consumo y dependen
show all

Neurociencia del consumo y dependencia de sustancias psicoactivas

Create successful ePaper yourself

Delete template?

Save as template?